Human Papillomavirus and Pregnancy

NCT01897129 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 546

Last updated 2013-07-11

No results posted yet for this study

Summary

Purpose Our study involves two hypotheses. One is that genital infection with HPV is associated with increased risk of miscarriage and preterm birth. The second hypothesis is that human papillomavirus can ascend from the vagina to the uterus through the cervix and cross the placental barrier. We wish to verify these hypotheses in our studies.

This study will determine the prevalence of HPV in Danish pregnant women and examine HPV's role in the aetiology of spontaneous abortion and preterm birth.

Conditions

  • HPV-infection in Pregnant Women

Sponsors & Collaborators

  • MCM Vaccines B.V.

    collaborator INDUSTRY
  • Region of Southern Denmark

    collaborator OTHER
  • University of Southern Denmark

    collaborator OTHER
  • Ulla Bonde van Zwol

    lead OTHER

Principal Investigators

  • Jan S Joergensen, Doctor · Supervisor

Eligibility

Min Age
15 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2014-11-30
Completion
2015-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01897129 on ClinicalTrials.gov